Literature DB >> 2668449

A historical perspective of elevated systolic vs diastolic blood pressure from an epidemiological and clinical trial viewpoint.

G H Rutan1, R H McDonald, L H Kuller.   

Abstract

The decision to use diastolic blood pressure as the basis for therapeutic intervention for hypertension was based primarily on clinical trials experience. The majority of observational studies shows as great or greater risk for elevated systolic blood pressure readings. Even many of the clinical trials in which a posteriori analyses have been performed confirm a greater effect of systolic rather than diastolic blood pressure as a predictor of coronary heart disease mortality. The current practice of using diastolic blood pressure readings as the sole treatment criterion should be reexamined in light of the observational studies and clinical trials reviewed here.

Entities:  

Mesh:

Year:  1989        PMID: 2668449     DOI: 10.1016/0895-4356(89)90010-3

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  14 in total

Review 1.  Diastolic pressure, systolic pressure, or pulse pressure?

Authors:  C Vlachopoulos; M O'Rourke
Journal:  Curr Hypertens Rep       Date:  2000-06       Impact factor: 5.369

2.  By how much does dietary salt reduction lower blood pressure? III--Analysis of data from trials of salt reduction.

Authors:  M R Law; C D Frost; N J Wald
Journal:  BMJ       Date:  1991-04-06

Review 3.  Primary prevention trials in cardiovascular disease.

Authors:  S J Pocock; S G Thompson
Journal:  J Epidemiol Community Health       Date:  1990-03       Impact factor: 3.710

Review 4.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

Review 5.  Prevalence and implications of uncontrolled systolic hypertension.

Authors:  William B Kannel
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

6.  Association of blood pressure in adolescence with birthweight.

Authors:  P O Pharoah; C J Stevenson; C R West
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

7.  Risk factors for stroke in middle aged British men.

Authors:  A G Shaper; A N Phillips; S J Pocock; M Walker; P W Macfarlane
Journal:  BMJ       Date:  1991-05-11

8.  Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study.

Authors:  Stanley S Franklin; Victor A Lopez; Nathan D Wong; Gary F Mitchell; Martin G Larson; Ramachandran S Vasan; Daniel Levy
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

9.  Communicating efficacy information based on composite scores in direct-to-consumer prescription drug advertising.

Authors:  Pamela A Williams; Amie C O'Donoghue; Helen W Sullivan; Jessica Fitts Willoughby; Claudia Squire; Sarah Parvanta; Kevin R Betts
Journal:  Patient Educ Couns       Date:  2015-11-05

10.  Relationships between blood pressure measurements and target organ damage: Data from the Korea women's chest pain registry.

Authors:  Min Gyu Kong; Hack-Lyoung Kim; Myung-A Kim; Mina Kim; Seong Mi Park; Hyun Ju Yoon; Mi Seung Shin; Kyung-Soon Hong; Gil Ja Shin; Wan-Joo Shim
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-10-25       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.